Stuttgart - Delayed Quote EUR

Blueprint Medicines Corp (2L9.SG)

Compare
84.58
-2.16
(-2.49%)
At close: December 30 at 8:08:25 AM GMT+1
Loading Chart for 2L9.SG
DELL
  • Previous Close 86.74
  • Open 84.58
  • Bid 84.04 x --
  • Ask 85.90 x --
  • Day's Range 84.58 - 84.58
  • 52 Week Range 66.50 - 111.05
  • Volume 0
  • Avg. Volume 23
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 13, 2025 - Feb 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2L9.SG

View More

Performance Overview: 2L9.SG

Trailing total returns as of 12/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2L9.SG
3.78%
S&P 500
23.31%

1-Year Return

2L9.SG
3.78%
S&P 500
23.31%

3-Year Return

2L9.SG
11.43%
S&P 500
23.08%

5-Year Return

2L9.SG
18.29%
S&P 500
82.59%

Compare To: 2L9.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2L9.SG

View More

Valuation Measures

As of 12/30/2024
  • Market Cap

    5.29B

  • Enterprise Value

    5.04B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.63

  • Price/Book (mrq)

    17.89

  • Enterprise Value/Revenue

    12.09

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2L9.SG

View More